Report Details:
15 Companies Covered
163 Pages
Market Highlights
The Herbal Medicine Market reached a valuation of USD 226.30 Billion in 2025 and is projected to climb from USD 246.90 Billion in 2026 to USD 540.90 Billion by 2035, expanding at a CAGR of 9.1% during the forecast period (2026–2035). Increasing consumer awareness about the adverse effects of allopathic drugs on health has changed consumer preferences, thus shifting the market focus toward natural remedies. In addition, during the COVID-19 pandemic, customers searching for immunity boosters increased the demand for herbal medicines.
The increased convenience offered by e-commerce has been a major market growth facilitator, particularly in regions where retail infrastructures are underdeveloped. The increased focus on preventive health care, the wellness culture in society, and government initiatives aimed at herbal R&D are also contributing to market growth.
Dabur, Himalaya Wellness, and Blackmores are a few of the businesses that make investments in global market expansion and product innovation. Dabur, for instance, strengthened its position in the thriving herbal wellness industry with the 2024 purchase of Kapiva, a herbal supplement start-up. In Europe, Schwabe Pharma has been introducing new herbal cognitive health supplements, and in the US, Nature's Way established a partnership with Amazon to release an exclusive line of herbal immunity products.
MRFR recognizes the following companies as the key players in the Global Herbal Medicine Market: Arkopharma, Bayer AG, BEOVITA, Hishimo Pharmaceuticals, Schaper & Brümmer, ZeinPharma Germany GmbH, Venus Pharma GmbH, Dasherb Corp., Arizona Natural Products, Blackmores, Himalaya Holdings Ltd., and Dr. Willmar Schwabe India Pvt. Ltd.
Segment Analysis
The Global Herbal Medicine Market has been segmented based on Form, Category, Source, and Distribution Channel.
Based on Form, the Capsules & Tablets segment dominated the market due to increased prescriptions and ease of consumption.
Based on Category, Herbal Pharmaceuticals accounted for the largest share, owing to the aging population and growing awareness of herbal therapeutics.
Based on the Distribution Channel, the E-commerce segment generated the highest revenue due to rising digitalization and increased mobile internet access.
Based on the Source, the Whole Plants segment led the market as they are extensively used for various medicinal formulations.
Region Analysis
By Region, the Herbal Medicine Market is segmented into North America, Europe, Asia-Pacific, and the Rest of the World. The primary reason why North America led the market was the high consumer awareness, as well as the growing acceptance of natural healthcare products. High consumer awareness alongside the growing use of herbal constituents in the region's cosmetics and dietary supplements propelled Europe to the second top position. The Asia-Pacific region is expected to increase rapidly and continue to strengthen due to rising disposable incomes and digital awareness, as well as the traditional roots of herbal medicine in countries like China and India.
Key Findings of the Study
- Herbal pharmaceuticals captured an estimated 28.3% of the Herbal Medicine Market share in 2025, reflecting strong demand for clinically validated plant-derived medicines in hospital settings.
- Herbal dietary supplements are poised to expand at a 10.2% CAGR through 2035, outpacing the overall Herbal Medicine Market as wellness-oriented consumers broaden their supplement routines.
- Roots and rhizomes accounted for approximately 39.8% of the Herbal Medicine Market in 2025, with turmeric- and ginseng-derived ingredients leading sourcing volumes.
- Roots and rhizomes accounted for approximately 39.8% of the Herbal Medicine Market in 2025, with turmeric- and ginseng-derived ingredients leading sourcing volumes.
- Tablets and capsules held about 42.5% revenue share in 2025, while teas and infusions registered an 11.9% CAGR, the fastest among dosage forms.
